RIEDEL NORBERT G, DIR, reported a transaction classified as grant at Eton Pharmaceuticals, Inc. involving 7757.000000 shares for an estimated $0.00. Reported holdings after the transaction were 294253.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
No officer title
The shares subject to the option shall vest on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on January 12, 2027.
Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
The restricted stock units vest in four equal annual installments beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.
0 other filings
0 recent txs